CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.
This article was sponsored by AstraZeneca.
An interview with Dr. Jennifer K. Lue, Assistant Professor of Medicine, Center for Lymphoid Malignancies, Division of Hematology and Oncology, Columbia University Irving Medical Center
April 29th 2015
The efficacy of Imbruvica (ibrutinib) and Zydelig (idelalisib) in chronic lymphocytic leukemia (CLL) suggests the drugs could potentially replace chemoimmunotherapy completely for some patients.
January 21st 2015
The vastly improved outlook for patients with chronic lymphocytic leukemia (CLL) was named the American Society of Clinical Oncology's inaugural "Cancer Advance of the Year."
December 27th 2014
The FDA has updated the label for Gazyva (obinutuzumab) plus chlorambucil to include data from stage 2 of the phase 3 CLL11 study, which detailed an improvement in progression-free survival as a frontline treatment for patients with chronic lymphocytic leukemia.
December 9th 2014
Zydelig was approved for several recurrent B-cell cancers, and now new data shows the drug also creates a response in older patients newly diagnosed with CLL or SLL.
November 15th 2014
Approved and investigational agents have improved outcomes for patients with follicular lymphoma; however a growing understanding of the origins and progression of the disease might offer further insights for future clinical development.
December 13th 2013
Gazyva may become a standard treatment for older, sicker patient with CLL.
December 17th 2012
When considering a stem cell transplantation, patients with cancer must be willing to take a chance.
January 5th 2012
In an early-phase study, PCI-32765, a BTK inhibitor, was shown to work against CLL, a type of non-Hodgkin lymphoma.
December 20th 2010
Updates from the annual meetings of the American Society of Hematology and the San Antonio Breast Cancer Symposium.
June 5th 2010
A wave of new treatments for chronic lymphocytic leukemia can help keep the disease at bay.
October 26th 2009
Advances in stem cell transplantation leads to a changing landscape in treating blood cancers, such as lymphoma, leukemia, and multiple myeloma.
March 13th 2009
The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.
December 9th 2008
News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.
September 8th 2008
Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.
December 11th 2007
Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.
September 12th 2007
Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.
April 9th 2007
CML survivor Erin Zammett Ruddy wants a baby. The trade-off may be her health.
December 19th 2006
Updates from the American Society of Hematology Meeting and the San Antonio Breast Cancer Symposium.
August 10th 2006
Survivors guided through territory of long-term and late effects.